Elevation Oncology Statistics Share Statistics Elevation Oncology has 59.22M
shares outstanding. The number of shares has increased by 8.2%
in one year.
Shares Outstanding 59.22M Shares Change (YoY) 8.2% Shares Change (QoQ) 0% Owned by Institutions (%) 67.63% Shares Floating 53M Failed to Deliver (FTD) Shares 3,228 FTD / Avg. Volume 0.25%
Short Selling Information The latest short interest is 4.43M, so 7.47% of the outstanding
shares have been sold short.
Short Interest 4.43M Short % of Shares Out 7.47% Short % of Float 9.14% Short Ratio (days to cover) 5.66
Valuation Ratios The PE ratio is -0.72 and the forward
PE ratio is -0.73.
Elevation Oncology's PEG ratio is
0.02.
PE Ratio -0.72 Forward PE -0.73 PS Ratio 0 Forward PS 0.1 PB Ratio 0.54 P/FCF Ratio -0.89 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Elevation Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 21.21,
with a Debt / Equity ratio of 0.52.
Current Ratio 21.21 Quick Ratio 21.21 Debt / Equity 0.52 Debt / EBITDA -0.7 Debt / FCF -0.86 Interest Coverage -37.16
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.31M Employee Count 34 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 43K Effective Tax Rate -0.1%
Stock Price Statistics The stock price has increased by -90.93% in the
last 52 weeks. The beta is 1.45, so Elevation Oncology's
price volatility has been higher than the market average.
Beta 1.45 52-Week Price Change -90.93% 50-Day Moving Average 0.32 200-Day Moving Average 0.53 Relative Strength Index (RSI) 49.4 Average Volume (20 Days) 1,316,584
Income Statement
Revenue n/a Gross Profit n/a Operating Income -44.7M Net Income -44.48M EBITDA -44.7M EBIT -43.24M Earnings Per Share (EPS) -0.78
Full Income Statement Balance Sheet The company has 49.46M in cash and 31.13M in
debt, giving a net cash position of 18.33M.
Cash & Cash Equivalents 49.46M Total Debt 31.13M Net Cash 18.33M Retained Earnings -240.46M Total Assets 82.22M Working Capital 77.96M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -36.36M
and capital expenditures 0, giving a free cash flow of -36.36M.
Operating Cash Flow -36.36M Capital Expenditures n/a Free Cash Flow -36.36M FCF Per Share -0.63
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
